Research Library
PRECLINICAL

TB-500 (Thymosin Beta-4)

Also known as: TB-500, Thymosin beta-4, Tβ4

Tissue BiologyPeptide SignalingVascular Biology
ClassificationThymosin beta-4-related peptide (actin-binding).
Catalog / SKUTB-500 (Thymosin Beta-4) · MX-TB500THY-005 · 5 mg
TargetsActin cytoskeleton; Cell migration pathways

Molecular Overview

Thymosin beta-4 (Tβ4) is a naturally occurring actin-sequestering peptide involved in cell migration and tissue biology. Commercially labeled 'TB-500' products are frequently associated with Tβ4 or its active fragment; identity of a specific preparation should be distinguished from endogenous Tβ4.

Mechanistic Background

Tβ4 binds G-actin and influences cytoskeletal dynamics and cell migration in experimental models.

What Researchers Study

Preclinical research has examined roles in cell migration, tissue repair models, and angiogenesis.

Evidence Landscape

Current evidence level: PRECLINICAL. Preclinical evidence does not equate to demonstrated human efficacy.

Research Limitations

Most evidence is preclinical. 'TB-500' commercial labeling may not be identical to endogenous Tβ4 used in studies.

Research Use Only

Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.